Nationwide Fund Advisors’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History

Nationwide Fund Advisors’s Portfolio NWBO Stock Details NWBO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-30,774	Closed	-$45K	–	3422
2016 Q1	$45K	Hold	30,774	–	–	﹤0.01%	3007
2015 Q4	$98K	Buy	30,774 +812	+3%	+$3.9K	﹤0.01%	2861
2015 Q3	$187K	Sell	29,962 -500	-2%	-$4.67K	﹤0.01%	2593
2015 Q2	$302K	Buy	30,462 +1,554	+5%	+$13.6K	﹤0.01%	2500
2015 Q1	$213K	Sell	28,908 -184	-0.6%	-$1.24K	﹤0.01%	2663
2014 Q4	$156K	Buy	29,092 +1,421	+5%	+$7.27K	﹤0.01%	2760
2014 Q3	$139K	Buy	27,671 +303	+1%	+$1.86K	﹤0.01%	2865
2014 Q2	$184K	Buy	+27,368	New	+$174K	﹤0.01%	2793

Other funds holding NWBO

WIM

Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Nationwide Fund Advisors's NWBO Position: Q2 2016 in Review

Nationwide Fund Advisors sold out of Northwest Biotherapeutics, Inc. Common stock (NWBO) in Q2 2016, closing a stake of 30,774 shares — an estimated $45K sold.

Nationwide Fund Advisors first reported a position in NWBO in Q2 2014 and held it in 8 quarters. The position peaked at $302K in Q2 2015. 64 funds tracked by Wall St. Rank hold NWBO as of Q2 2016.

Nationwide Fund Advisors reported no remaining Northwest Biotherapeutics, Inc. Common stock position as of Q2 2016 after selling out during the quarter.
Nationwide Fund Advisors sold 30,774 Northwest Biotherapeutics, Inc. Common stock shares in Q2 2016, an estimated $45K.
Nationwide Fund Advisors first reported a position in Northwest Biotherapeutics, Inc. Common stock in Q2 2014 and held it in 8 quarters.
Nationwide Fund Advisors's Northwest Biotherapeutics, Inc. Common stock position peaked at $302K in Q2 2015.
64 funds tracked by Wall St. Rank held Northwest Biotherapeutics, Inc. Common stock as of Q2 2016.

Based on Nationwide Fund Advisors's 13F filing for Q2 2016, filed 9 Aug 2016.